ChIPac Method for Histone H3 Tail Cleavage Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack a reliable way to identify and map regions of histone H3 N-terminal tail cleavage in mammals, which is crucial for understanding its role in epigenetic regulation and gene expression, particularly in osteoclastogenesis.
Innovation Solution
Development of the ChIP of acetylated chromatin (ChIPac) method using an H3K14ac-specific antibody to selectively enrich chromatin with cleaved H3 N-terminal tails, allowing for the identification of H3 N-terminal tail-cleaved regions through crosslinking with methylene blue and acetylation with acetic anhydride, followed by quantitative PCR or NextGen sequencing analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional chromatin immunoprecipitation methods are used, then general chromatin regions can be analyzed, but specific cleaved H3 N-terminal tail regions cannot be reliably identified
Solution Approach 1:
The method performs preliminary acetylation of all unmodified lysine residues in the chromatin sample before immunoprecipitation. This preliminary chemical modification ensures that only chromatin with cleaved H3 N-terminal tails (which lack lysines at the N-terminus and thus cannot be acetylated) will be selectively enriched by the anti-acetylated lysine antibody, enabling reliable identification of cleaved regions
Solution Approach 2:
The invention uses acetylated lysine residues as an intermediary marker to indirectly detect H3 N-terminal tail cleavage. Since the H3 N-terminal tail contains lysine residues that are normally acetylated, their absence due to cleavage can be detected by the absence of acetylated lysine signal in specific chromatin regions, providing a reliable indirect measurement method
2Loss of information
If H3 N-terminal tail cleavage is not detected, then epigenetic regulation mechanisms remain unknown, but developing detection methods increases experimental complexity
Solution Approach 1:
The method uses a universal anti-acetylated lysine antibody that can detect acetylation marks on any lysine residue throughout the chromatin sample. This universal approach allows the same antibody to serve multiple functions: detecting normal acetylated regions, identifying cleaved regions by absence of signal, and analyzing various histone modifications simultaneously, thereby reducing the need for multiple specialized reagents
Solution Approach 2:
The method converts the harmful effect of H3 N-terminal tail cleavage (loss of epigenetic information) into a beneficial detection signal. By acetylating all unmodified lysines and then using immunoprecipitation, the absence of acetylated lysine signal at specific genomic loci directly indicates where cleavage has occurred, transforming the problem of detecting cleavage into the simpler task of detecting acetylation patterns
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the precise identification of H3 N-terminal tail-cleaved regions, demonstrating that MMP-9-dependent H3 N-terminal proteolysis is essential for osteoclast differentiation and gene activation, providing insights into the mechanistic functions of H3 tail cleavage in chromatin regulation.
Implementation Method 1
contacting a cell containing chromatin with methylene blue or an equivalent thereof after exposure to white light or an equivalent of the white light to crosslink proteins in the cell
Implementation Method 2
acetylating all unmodified lysine residues by contacting the chromatin with acetic anhydride
Data Source
AI summary
Although limited proteolysis of the histone H3 N-terminal tail (H3NT) is frequently observed during mammalian differentiation, the specific genomic sites targeted for H3NT proteolysis and the functional significance of H3NT cleavage remain largely unknown. Here Applicant reports the first method to identify and examine H3NT-cleaved regions in mammals, called ChIP of acetylated chromatin (ChIPac). By applying ChIPac-Seq to an established cell model of osteoclast differentiation, Applicant discovered that H3NT proteolysis is selectively targeted near transcription start sites of a small group of genes and that most H3NT-cleaved genes displayed significant expression changes during osteoclastogenesis. Applicant also discovered that the principal H3NT protease of osteoclastogenesis is matrix metalloproteinase 9 (MMP-9). In contrast to other known H3NT proteases, MMP-9 primarily cleaved H3K18-Q19 in vitro and in cells. Furthermore, Applicant's results support CBP/p300-mediated acetylation of H3K18 as a central regulator of MMP-9 H3NT protease activity both in vitro and at H3NT-cleavage sites during osteoclastogenesis. Importantly, Applicant found that abrogation of H3NT proteolysis impaired osteoclastogenic gene activation concomitant with defective osteoclast differentiation. Applicant's collective results support the necessity of MMP-9-dependent H3NT proteolysis in regulating gene pathways required for proficient osteoclastogenesis.